Effect of pentoxifylline on diabetic distal polyneuropathy in type 2 diabetic patients: A randomized trial
Background: Diabetes is one of the most common causes of peripheral neuropathy. There are no known cures for diabetic neuropathy. Pentoxifylline could theoretically be a beneficial treatment for diabetic sensory neuropathy, but there is not enough evidence to prove its effect. The aim of this study...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
| Series: | Journal of Research in Medical Sciences |
| Subjects: | |
| Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2019;volume=24;issue=1;spage=89;epage=89;aulast=Hosseini |
| _version_ | 1818506029196902400 |
|---|---|
| author | Frahad Hosseini Abolfazl Mohammadbeigi Mohammad Aghaali Razieh Borujerdi Mahmoud Parham |
| author_facet | Frahad Hosseini Abolfazl Mohammadbeigi Mohammad Aghaali Razieh Borujerdi Mahmoud Parham |
| author_sort | Frahad Hosseini |
| collection | DOAJ |
| description | Background: Diabetes is one of the most common causes of peripheral neuropathy. There are no known cures for diabetic neuropathy. Pentoxifylline could theoretically be a beneficial treatment for diabetic sensory neuropathy, but there is not enough evidence to prove its effect. The aim of this study was to investigate the effect of pentoxifylline on distal diabetic neuropathy. Materials and Methods: In this randomized double-blinded placebo-controlled trial, 60 patients with diabetic peripheral neuropathy were randomized into two groups. The intervention group received Vitamin B1 (100 mg twice daily) and pentoxifylline (400 mg twice daily) and control group received Vitamin B1 (100 mg twice daily) and placebo (twice daily) for 2 months. Before and after the intervention, the symptoms of distal polyneuropathy were recorded by the Michigan Neuropathy Screening Instrument. ANCOVA, Paired t-test, unpaired t-test, Chi-square, and Fisher's exact test were used to compare changes in symptoms and sign of distal polyneuropathy. Results: The mean age of patients was 57.1 ± 8.02 years. There was no significant difference between the two groups in regard to the baseline variables. Blood pressure, body mass index, and blood glucose did not change significantly during the study. In the pentoxifylline group, the symptoms of peripheral neuropathy were significantly improved, in comparison with placebo group (P = 0.042). Conclusion: This study showed pentoxifylline could be effective in reducing the symptoms of distal diabetic neuropathy. |
| first_indexed | 2024-12-10T21:58:54Z |
| format | Article |
| id | doaj.art-ef1b7b5b05f44a35af137c03864145a3 |
| institution | Directory Open Access Journal |
| issn | 1735-1995 1735-7136 |
| language | English |
| last_indexed | 2024-12-10T21:58:54Z |
| publishDate | 2019-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Research in Medical Sciences |
| spelling | doaj.art-ef1b7b5b05f44a35af137c03864145a32022-12-22T01:31:58ZengWolters Kluwer Medknow PublicationsJournal of Research in Medical Sciences1735-19951735-71362019-01-01241898910.4103/jrms.JRMS_115_18Effect of pentoxifylline on diabetic distal polyneuropathy in type 2 diabetic patients: A randomized trialFrahad HosseiniAbolfazl MohammadbeigiMohammad AghaaliRazieh BorujerdiMahmoud ParhamBackground: Diabetes is one of the most common causes of peripheral neuropathy. There are no known cures for diabetic neuropathy. Pentoxifylline could theoretically be a beneficial treatment for diabetic sensory neuropathy, but there is not enough evidence to prove its effect. The aim of this study was to investigate the effect of pentoxifylline on distal diabetic neuropathy. Materials and Methods: In this randomized double-blinded placebo-controlled trial, 60 patients with diabetic peripheral neuropathy were randomized into two groups. The intervention group received Vitamin B1 (100 mg twice daily) and pentoxifylline (400 mg twice daily) and control group received Vitamin B1 (100 mg twice daily) and placebo (twice daily) for 2 months. Before and after the intervention, the symptoms of distal polyneuropathy were recorded by the Michigan Neuropathy Screening Instrument. ANCOVA, Paired t-test, unpaired t-test, Chi-square, and Fisher's exact test were used to compare changes in symptoms and sign of distal polyneuropathy. Results: The mean age of patients was 57.1 ± 8.02 years. There was no significant difference between the two groups in regard to the baseline variables. Blood pressure, body mass index, and blood glucose did not change significantly during the study. In the pentoxifylline group, the symptoms of peripheral neuropathy were significantly improved, in comparison with placebo group (P = 0.042). Conclusion: This study showed pentoxifylline could be effective in reducing the symptoms of distal diabetic neuropathy.http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2019;volume=24;issue=1;spage=89;epage=89;aulast=Hosseinidiabetespentoxifyllineperipheral neuropathy |
| spellingShingle | Frahad Hosseini Abolfazl Mohammadbeigi Mohammad Aghaali Razieh Borujerdi Mahmoud Parham Effect of pentoxifylline on diabetic distal polyneuropathy in type 2 diabetic patients: A randomized trial Journal of Research in Medical Sciences diabetes pentoxifylline peripheral neuropathy |
| title | Effect of pentoxifylline on diabetic distal polyneuropathy in type 2 diabetic patients: A randomized trial |
| title_full | Effect of pentoxifylline on diabetic distal polyneuropathy in type 2 diabetic patients: A randomized trial |
| title_fullStr | Effect of pentoxifylline on diabetic distal polyneuropathy in type 2 diabetic patients: A randomized trial |
| title_full_unstemmed | Effect of pentoxifylline on diabetic distal polyneuropathy in type 2 diabetic patients: A randomized trial |
| title_short | Effect of pentoxifylline on diabetic distal polyneuropathy in type 2 diabetic patients: A randomized trial |
| title_sort | effect of pentoxifylline on diabetic distal polyneuropathy in type 2 diabetic patients a randomized trial |
| topic | diabetes pentoxifylline peripheral neuropathy |
| url | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2019;volume=24;issue=1;spage=89;epage=89;aulast=Hosseini |
| work_keys_str_mv | AT frahadhosseini effectofpentoxifyllineondiabeticdistalpolyneuropathyintype2diabeticpatientsarandomizedtrial AT abolfazlmohammadbeigi effectofpentoxifyllineondiabeticdistalpolyneuropathyintype2diabeticpatientsarandomizedtrial AT mohammadaghaali effectofpentoxifyllineondiabeticdistalpolyneuropathyintype2diabeticpatientsarandomizedtrial AT raziehborujerdi effectofpentoxifyllineondiabeticdistalpolyneuropathyintype2diabeticpatientsarandomizedtrial AT mahmoudparham effectofpentoxifyllineondiabeticdistalpolyneuropathyintype2diabeticpatientsarandomizedtrial |